Entecavir 50771-0013
Product NDC
50771-0013- Manufacturer
- Yaopharma Co., Ltd.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA212201
Need to source Entecavir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Entecavir | .5 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Nucleoside Analog [EXT]Nucleoside Reverse Transcriptase Inhibitors [MoA]
Packaging Options(2)
30 TABLET, FILM COATED in 1 BOTTLE (50771-013-01)
90 TABLET, FILM COATED in 1 BOTTLE (50771-013-02)